New Delhi [India] : After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Bharat Biotech, the manufacturer of Covaxin, has submitted data for clinical trials in the age group of 2-18 years to Central Drugs Standard Control Organisation (CDSCO). The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee and has provided their positive recommendations.
Must Read
- Covaxin gets emergency approval for children aged 2-18 years
- Vaccine for Children: Biden administration announces plan to…
- Uttar Pradesh to start vaccinating children aged 15-18 years…
- Bharat Biotech's partner seeks Covaxin approval in US for…
- Argentina to start COVID-19 vaccination of children aged…
- US formally recommends Pfizer COVID-19 vaccine for children…
- Israel approves COVID-19 vaccination for children aged 5-11
- COVID-19 vaccination: Registration for children aged 15-18…
- Preparations for COVID-19 vaccination for children aged…
- Over 7 lakh children aged 15-18 yrs register for COVID-19…